Patient and treatment pathways for toxoplasmosis in the United States: data analysis of the Vizient Health Systems Data from 2011 to 2017

Toxoplasmosis causes substantial morbidity and mortality in the United States (US). Clinical manifestations to toxoplasmosis vary and there is limited information on incidence or treatment patterns in the US. Treatment pathways for pyrimethamine-based regimens and trimethoprim-sulfamethoxazole (TMP-...

Descripción completa

Detalles Bibliográficos
Autores principales: Belk, Kathy, Connolly, Mark P., Schlesinger, Lisa, Ben-Harari, Ruben R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6327601/
https://www.ncbi.nlm.nih.gov/pubmed/30526421
http://dx.doi.org/10.1080/20477724.2018.1552644

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6327601/
https://www.ncbi.nlm.nih.gov/pubmed/30526421
http://dx.doi.org/10.1080/20477724.2018.1552644

Ejemplares similares